This case report highlights an unusual presentation of Adult Still’s Disease (ASD), a rare systemic inflammatory disorder, in a 26-year-old woman who exhibited atypical skin symptoms without classical ...

In March 2025, the Advisory Committee on Dangerous Pathogens (ACDP) advised that clade I mpox no longer meets the criteria for a high consequence infectious disease (HCID) and recommended derogation.

Skin lesions change dramatically over time and vary among patients, making it difficult to predict when someone is no longer contagious.

We tested over 30 concealers to find the best ones for acne-prone skin. Shop concealers from Haus Labs, Tower 28, Clinique and more.

Cutaneous lesions were managed with intermittent topical corticosteroids, and chest pain did not recur. This case highlights the importance of maintaining vigilance for SAPHO syndrome in patients with ...

Your pimple may be more problematic than you realize, as a Harvard-trained dermatologist warns that some benign-seeming blemishes could be cancerous.

After more than 50 years, the assessment of traumatic brain injuries gets an overhaul. Clinicians say the proposed framework will lead to more accurate diagnoses and treatment, providing more rigorous ...

Using clinical images in DL systems may improve skin cancer detection by providing a more inclusive representation of real-world lesions. DenseNet models outperformed others in binary ...

Skin purging looks a lot like acne, but they are not the same. Skin purging may have many of the skin issues of acne, but it’s the storm before the calm, versus the other way around.

Discover the growth rates of 5 different skin cancers, from slow-developing basal cell carcinomas to aggressive melanomas, plus essential prevention strategies.

Here’s what dermatologists say you should know about skin cancer screenings. Who should get a skin cancer screening? Does everyone need to get an annual skin check with a dermatologist?

Calcipotriol-plus–5-FU therapy activates immune pathways, offering long-lasting protection against squamous cell carcinoma by targeting precancerous lesions.